Results with Avastin Therapy
Avastin is approved to treat GBM in adult patients whose cancer has progressed after prior treatment.
- In studies of people with GBM, Avastin has been shown to shrink tumors in some people
- Tumor response is based on MRI and stable or decreasing corticosteroid use. An MRI does not necessarily distinguish between the tumor, swelling (edema), or tissue death (necrosis) caused by prior radiation therapy
- Currently, no data have shown whether or not Avastin improves disease-related symptoms or survival in people previously treated for GBM.
Studies have also shown that there are some serious side effects that may occur with Avastin therapy.
Side effects of Avastin in GBM
In a clinical trial, people who took Avastin alone for GBM experienced the following side effects:
Two deaths were possibly related to Avastin: one from bleeding in the abdomen, and one from severely reduced white blood cell counts that led to infection.
View reference
In a clinical trial, people receiving Avastin alone or Avastin plus irinotecan experienced the following side effects:


